Pacific Biosciences Return On Equity vs. Return On Asset
| PACB Stock | USD 2.34 0.16 7.34% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.44) | Current Value (0.46) | Quarterly Volatility 0.5070375 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.29 | 0.2632 |
|
|
For Pacific Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pacific Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pacific Biosciences of utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pacific Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pacific Biosciences of over time as well as its relative position and ranking within its peers.
Pacific |
Pacific Biosciences' Revenue Breakdown by Earning Segment
Check out Your Equity Center.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 0.64 | Quarterly Revenue Growth (0.28) | Return On Assets (0.11) | Return On Equity (0.65) |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pacific Biosciences Return On Asset vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pacific Biosciences's current stock value. Our valuation model uses many indicators to compare Pacific Biosciences value to that of its competitors to determine the firm's financial worth. Pacific Biosciences of is regarded fourth in return on equity category among its peers. It is regarded second in return on asset category among its peers . At present, Pacific Biosciences' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pacific Biosciences' earnings, one of the primary drivers of an investment's value.Pacific Biosciences' Earnings Breakdown by Geography
Pacific Return On Asset vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Pacific Biosciences |
| = | -0.65 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Pacific Biosciences |
| = | -0.11 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Pacific Return On Asset Comparison
Pacific Biosciences is currently under evaluation in return on asset category among its peers.
Pacific Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pacific Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pacific Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Pacific Biosciences' change in net profit over the period of time. It can combine multiple indicators of Pacific Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 219 K | 229.9 K | |
| Operating Income | -334.5 M | -317.7 M | |
| Income Before Tax | -318.2 M | -302.3 M | |
| Total Other Income Expense Net | 16.3 M | 17.1 M | |
| Net Loss | -306.7 M | -291.4 M | |
| Income Tax Expense | -11.4 M | -12 M | |
| Net Loss | -309.1 M | -293.6 M | |
| Non Operating Income Net Other | 107 K | 101.6 K | |
| Net Loss | -282.8 M | -268.7 M | |
| Interest Income | 2.3 M | 2.3 M | |
| Net Interest Income | -14.4 M | -13.7 M | |
| Change To Netincome | 100.1 M | 105.1 M | |
| Net Loss | (1.21) | (1.27) | |
| Income Quality | 0.84 | 0.90 | |
| Net Income Per E B T | 0.96 | 0.70 |
Pacific Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pacific Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pacific Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pacific Biosciences' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Pacific Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Use Investing Themes to Complement your Pacific Biosciences position
In addition to having Pacific Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
To fully project Pacific Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Pacific Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Pacific Biosciences' income statement, its balance sheet, and the statement of cash flows.